Your browser doesn't support javascript.
loading
Pre-radiotherapy daily exercise training in non-small cell lung cancer: A feasibility study.
Egegaard, Trine; Rohold, Julie; Lillelund, Christian; Persson, Gitte; Quist, Morten.
Afiliación
  • Egegaard T; The University Hospitals for Health Sciences, University Hospital of Copenhagen, Denmark.
  • Rohold J; The University Hospitals for Health Sciences, University Hospital of Copenhagen, Denmark.
  • Lillelund C; The University Hospitals for Health Sciences, University Hospital of Copenhagen, Denmark.
  • Persson G; Department of Oncology, University Hospital of Copenhagen, Denmark.
  • Quist M; The University Hospitals for Health Sciences, University Hospital of Copenhagen, Denmark.
Rep Pract Oncol Radiother ; 24(4): 375-382, 2019.
Article en En | MEDLINE | ID: mdl-31289452
ABSTRACT

AIM:

To examine the feasibility of an individual, supervised, structured moderate-to-high intensity cycle ergometer exercise training immediately before radiotherapy in patients undergoing concomitant chemoradiotherapy for locally advanced non-small cell lung cancer (NSCLC).

BACKGROUND:

Lung cancer is the most common form of cancer. Despite significant advancements in therapy and supportive care it is still the leading cause of cancer-related death worldwide. MATERIALS AND

METHODS:

Randomized controlled study design; patients with NSCLC receiving concomitant chemoradiotherapy were recruited and randomly assigned to either the exercise (EXE) or the control (CON) group. Exercise training consisted of 20 min moderate-to-high intensity aerobic interval training 5 times per week (Mon-Fri) prior to radiotherapy. Secondary outcomes were assessed at baseline and after 7 weeks peak oxygen consumption (VO2peak), functional capacity (6MWD), pulmonary function (FEV1), psychosocial parameters (quality of life (FACT-L), anxiety and depression (HADS)) and cancer-related side effects (reported daily).

RESULTS:

Fifteen patients were included. All patients completed a baseline test, while 13 patients were eligible for a posttest. The recruiting rate was 44.1% and the overall attendance rate to exercise was 90.0% with an adherence rate to full exercise participation of 88.1%. No adverse events or any unexpected reactions were observed during the exercise sessions. No significant differences were observed within or between groups from baseline to post intervention in any of the secondary outcomes.

CONCLUSION:

This study demonstrated 'proof of principle' that daily moderate-to-high intensity cycle ergometer exercise was feasible, safe and well tolerated among newly diagnosed patients with locally advanced NSCLC undergoing concomitant chemoradiotherapy. Larger randomized controlled trials are warranted.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Aspecto: Patient_preference Idioma: En Revista: Rep Pract Oncol Radiother Año: 2019 Tipo del documento: Article País de afiliación: Dinamarca Pais de publicación: PL / POLAND / POLONIA / POLÔNIA

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Aspecto: Patient_preference Idioma: En Revista: Rep Pract Oncol Radiother Año: 2019 Tipo del documento: Article País de afiliación: Dinamarca Pais de publicación: PL / POLAND / POLONIA / POLÔNIA